BIOMAT Database Logo BIOMAT Database Logo

Characteristics of cell lines established from human gastric carcinoma. 1990

J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Cancer Research Institute, College of Medicine, Seoul National University, Korea.

We report the establishment and characterization of four continuous cell lines derived from human primary and metastatic gastric carcinomas, and we compare their properties with a panel of colorectal carcinoma cell lines previously established and reported by us. Our success rate in culturing gastric carcinomas was relatively low, especially from primary tumors, compared to colorectal carcinoma. These observations may reflect the relatively modest number of gastric carcinoma cell lines established (mainly from Japan), compared to the abundance of colorectal carcinoma lines established worldwide. All four gastric lines expressed the surface glycoproteins carcinoembryonic antigen and TAG-72 and three lines expressed CA 19-9. Two of the lines expressed aromatic amino acid decarboxylase but lacked other markers for neuroendocrine differentiation. All four lines were positive for vasoactive intestinal peptide receptors but lacked gastrin receptors. In addition, two lines expressed receptors for muscarinic/cholinergic receptors but not beta-adrenergic receptors. Cytogenetic evidence for gene amplification was present in the cell lines. All four lines contained varying numbers of double-minute chromosomes. One line, SNU-16, was amplified for the c-myc proto-oncogene and contained four homogeneously staining regions. While c-myc and c-erb-B-2 RNA were expressed by all lines, there was no evidence of amplification or overexpression of several other proto-oncogenes and growth factors. The multiple properties we have described in our gastric carcinoma cell lines are remarkably similar to those found in the panel of colorectal carcinoma cell lines. These properties include morphology, growth characteristics, expression of surface glycoproteins, partial expression of neuroendocrine cell markers, frequent chromosomal evidence of gene amplification, and occasional amplification of the c-myc proto-oncogene. Our four well characterized cell lines should provide useful additions to the modest number currently available for in vitro studies of gastric carcinoma.

UI MeSH Term Description Entries
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D011964 Receptors, Gastrointestinal Hormone Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems. Gastrointestinal Hormone Receptors,Intestinal Hormone Receptors,Receptors, Gastrointestinal Peptides,Gastrointestinal Hormone Receptor,Intestinal Hormone Receptor,Receptors, Gastrointestinal Hormones,Receptors, Intestinal Hormone,Gastrointestinal Hormones Receptors,Gastrointestinal Peptides Receptors,Hormone Receptor, Gastrointestinal,Hormone Receptor, Intestinal,Hormone Receptors, Gastrointestinal,Hormone Receptors, Intestinal,Hormones Receptors, Gastrointestinal,Peptides Receptors, Gastrointestinal,Receptor, Gastrointestinal Hormone,Receptor, Intestinal Hormone
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm

Related Publications

J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Characteristics of cell lines established from human colorectal carcinoma.
December 1987, Cancer research,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Different genome organization in two new cell lines established from human gastric carcinoma.
September 1998, Cancer genetics and cytogenetics,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Differential characteristics of two newly established human breast carcinoma cell lines.
March 1985, Cancer research,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Characterization of cell lines established from human hepatocellular carcinoma.
July 1995, International journal of cancer,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Characterization of human gastric adenocarcinoma cell lines established from peritoneal ascites.
April 2018, Oncology letters,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Characteristics of human lymphoblastoid cell lines established in culture.
January 1981, Pathologica,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Characteristics of human gastric carcinoma cell lines with induced multidrug resistance.
January 1997, Anticancer research,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Molecular characteristics of eight gastric cancer cell lines established in Japan.
October 2000, Pathology international,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
[Cytological and karyological characteristics of established cell lines of human origin. II. Characteristics of 2 HeLa cell lines].
March 1972, Tsitologiia,
J G Park, and H Frucht, and R V LaRocca, and D P Bliss, and Y Kurita, and T R Chen, and J G Henslee, and J B Trepel, and R T Jensen, and B E Johnson
Karyotypic analysis of seven established human esophageal carcinoma cell lines.
January 1994, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!